CAS RN: 98358-90-8
DBD-F [=4-(N,N-Dimethylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole] [for HPLC Labeling]
Product Availability
Choose a grade to view its available package options.
3 package records2 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260115 |
100mg |
In stock |
| Inquiry |
| Batchno.20251115 |
25mg |
In stock |
Shanghai | Inquiry |
| Batchno.20260108 |
25mg |
Out of stock |
| Inquiry |
-
Product code:
ICTA5595
-
Purity/Analytical Methods:
>98.0%(HPLC)
GET A QUOTE
98358-90-8 / 7-fluoro-N,N-dimethyl-2,1,3-benzoxadiazole-4-sulfonamide
Standard CAS: 98358-90-8
Multi CAS: Yes
Basic Information
CAS
98358-90-8
Multi CAS
Yes
Molecular Formula
C8FH8N3O3S
Molecular Weight
245.230000
Exact Mass
245.027040
InChI
InChI=1S/C8H8FN3O3S/c1-12(2)16(13,14)6-4-3-5(9)7-8(6)11-15-10-7/h3-4H,1-2H3
InChIKey
YZWANFXENNWOOR-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
16
Aromatic heavy atom count
9
Fraction Csp3
0.25
Rotatable bonds
2
H-bond acceptors
5
Molar refractivity
52.63
TPSA
76.3
LogP / Solubility
WLOGP
0.61
MLOGP
0.54
XLogP3
0.4
Consensus LogP
0.52
Log S (ESOL)
-2.03
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.01
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.78
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5